TOPAMAX Side Effects

7022308-6 | Disturbance In Attention, Dyspnoea, Mental Impairment, Pneumonia, Tic, Trigeminal Neuralgia
on Sep 22, 2010 Female patient from UNITED STATES , weighting 232.0 lb, was diagnosed with migraine (What is migraine?), blood cholesterol increased, thyroid disorder, hypertension and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: disturbance in attention, dyspnoea, mental impairment, pneumonia (What is pneumonia?), tic (What is tic?), trigeminal neuralgia (What is trigeminal neuralgia?). Topamax dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), ZOCOR (View Zocor Review and Zocor Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

7021980-4 | Coma, Refusal Of Treatment By Patient, Self Injurious Behaviour
Patient was taking Topamax (View Usage). Patient had the following side effects: coma, refusal of treatment by patient, self injurious behaviour on Sep 21, 2010 from ITALY Additional patient health information: Female patient , 63 years of age, . Topamax dosage: . During the same period patient was treated with LENDORMIN (View Lendormin Review and Lendormin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

7019956-6 | Coma, Shock
Adverse event was reported on Sep 21, 2010 by a Female patient taking Topamax (View Usage) (Dosage: ) . Location: AUSTRIA , 41 years of age, weighting 282.2 lb, After Topamax was administered, patient had the following side effects: coma, shock. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CAFFEINE (View Caffeine Review and Caffeine Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), NICOTINE (View Nicotine Review and Nicotine Label ), ALCOHOL (View Alcohol Review and Alcohol Label ).

7019584-2 | Alcohol Interaction, Alopecia, Anger, Anxiety, Decreased Appetite, Depression, Diarrhoea, Disturbance In Attention
on Sep 28, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with migraine (What is migraine?) and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol interaction, alopecia, anger, anxiety (What is anxiety?), decreased appetite, depression (What is depression?), diarrhoea, disturbance in attention. Topamax dosage: 200mg 1x Daily Po.


7017766-7 | Condition Aggravated, Depression, Feeling Abnormal, Headache, Pain, Suicidal Ideation
on Sep 27, 2010 Female patient from UNITED STATES , 17 years of age, weighting 185.0 lb, was diagnosed with headache (What is headache?), migraine (What is migraine?) and was treated with Topamax (View Usage). Patient had the following side effects: condition aggravated, depression (What is depression?), feeling abnormal, headache (What is headache?), pain (What is pain?), suicidal ideation. Topamax dosage: 1-2 Tablets Once A Week Maybe Po. During the same period patient was treated with EPIDRIN NOT LISTED ON THE WAL MART PHARMACY LABEL (1 Capsule Every 2 Hrs As Need 4 Times A Day Po) (View Epidrin Not Listed On The Wal-mart Pharmacy Label Review and Epidrin Not Listed On The Wal-mart Pharmacy Label Label ), FIORICET (View Fioricet Review and Fioricet Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

7013213-X | Aphasia, Cyst, Eye Pain, Feeling Abnormal, Hypertension, Insomnia, Treatment Noncompliance, Visual Impairment
Patient was taking Topamax (View Usage). After Topamax was administered, patient had the following side effects: aphasia (What is aphasia?), cyst, eye pain, feeling abnormal, hypertension, insomnia, treatment noncompliance, visual impairment on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 198.0 lb, was diagnosed with fibromyalgia, depression (What is depression?) and. Topamax dosage: .

7013212-8 | Deep Vein Thrombosis, Renal Failure Acute
Adverse event was reported on Sep 16, 2010 by a Male patient taking Topamax (View Usage) (Dosage: 50 Mg Every Pm 25 Mg Every Pm) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), renal failure acute. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), ABILIFY (View Abilify Review and Abilify Label ). Patient was hospitalized.

7013210-4 | Abasia, Balance Disorder, Convulsion, Dizziness, Dysarthria, Headache, Vision Blurred
on Sep 15, 2010 Female patient from UNITED KINGDOM , 14 years of age, was diagnosed with petit mal epilepsy and was treated with Topamax (View Usage). Patient had the following side effects: abasia, balance disorder, convulsion, dizziness (What is dizziness?), dysarthria, headache (What is headache?), vision blurred. Topamax dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

7013209-8 | Acidosis, Restlessness
on Sep 17, 2010 Female patient from UNITED KINGDOM , child 2 years of age, weighting 24.25 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: acidosis, restlessness. Topamax dosage: .

7013207-4 | Nephrocalcinosis
Patient was taking Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: nephrocalcinosis on Sep 17, 2010 from GERMANY Additional patient health information: Male patient , weighting 34.39 lb, . Topamax dosage: . Patient was hospitalized.

7005115-X | Tubulointerstitial Nephritis
Adverse event was reported on Sep 13, 2010 by a Male patient taking Topamax (View Usage) (Dosage: ) . Location: GERMANY , 47 years of age, Patient had the following side effects: tubulointerstitial nephritis.

7001640-6 | Abnormal Behaviour, Anxiety, Attention Deficit/hyperactivity Disorder, Decreased Appetite, Hypokinesia, Vision Blurred, Weight Decreased
on Sep 11, 2010 Male patient from MEXICO , child 7 years of age, weighting 48.50 lb, was diagnosed with ataxia (What is ataxia?), convulsion, attention deficit/hyperactivity disorder, medical diet and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: abnormal behaviour, anxiety (What is anxiety?), attention deficit/hyperactivity disorder, decreased appetite, hypokinesia, vision blurred, weight decreased. Topamax dosage: One Tablet At Morning And One And Half Tablet At Night. During the same period patient was treated with STRATTERA (View Strattera Review and Strattera Label ), EPIVAL (Two Tablets At Morning And Three Tablets At Night) (View Epival Review and Epival Label ), ENSURE (View Ensure Review and Ensure Label ).

7000603-4 | Deafness Bilateral, Treatment Noncompliance
on Sep 10, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with migraine prophylaxis, pain in extremity, back pain (What is back pain?) and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: deafness bilateral, treatment noncompliance. Topamax dosage: . During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), BUPROPION (View Bupropion Review and Bupropion Label ), SUMATRIPTAN (View Sumatriptan Review and Sumatriptan Label ).

6988807-8 | Atrioventricular Septal Defect, Heart Disease Congenital, Kidney Malformation, Limb Malformation, Oesophageal Atresia, Spine Malformation, Tracheal Stenosis, Tracheo-oesophageal Fistula
Patient was taking Topamax (View Usage). Patient had the following side effects: atrioventricular septal defect, heart disease congenital, kidney malformation, limb malformation, oesophageal atresia, spine malformation, tracheal stenosis, tracheo-oesophageal fistula on Aug 22, 2006 from GERMANY Additional patient health information: Male patient , weighting 6.31 lb, was diagnosed with epilepsy (What is epilepsy?) and. Topamax dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ). Patient was hospitalized.

6985598-1 | Acidosis
Adverse event was reported on Sep 06, 2010 by a Male patient taking Topamax (View Usage) (Dosage: ) was diagnosed with myoclonic epilepsy and. Location: GERMANY , weighting 94.80 lb, After Topamax was administered, patient had the following side effects: acidosis. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), PETINUTIN (View Petinutin Review and Petinutin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), CREON (1 Dose Per Snack) (View Creon Review and Creon Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), NULYTELY (View Nulytely Review and Nulytely Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ).

6983368-1 | Nephrolithiasis
on Sep 14, 2010 Female patient from UNITED STATES , 40 years of age, weighting 140.0 lb, was diagnosed with migraine (What is migraine?) and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis. Topamax dosage: 150-200mg Daily Po.

6980574-7 | Atrioventricular Septal Defect, Heart Disease Congenital, Kidney Malformation, Limb Malformation, Oesophageal Atresia, Spine Malformation, Tracheal Stenosis, Tracheo-oesophageal Fistula
on Aug 22, 2006 Male patient from GERMANY , weighting 6.31 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). Patient had the following side effects: atrioventricular septal defect, heart disease congenital, kidney malformation, limb malformation, oesophageal atresia, spine malformation, tracheal stenosis, tracheo-oesophageal fistula. Topamax dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ). Patient was hospitalized.

6980084-7 | Anxiety, Decreased Appetite, Depression, Fibromyalgia, Hypermobility Syndrome, Rash, Raynaud's Phenomenon, Skin Nodule, Tinnitus
Patient was taking Topamax (View Usage). After Topamax was administered, patient had the following side effects: anxiety (What is anxiety?), decreased appetite, depression (What is depression?), fibromyalgia, hypermobility syndrome, rash (What is rash?), raynaud's phenomenon, skin nodule, tinnitus (What is tinnitus?) on Jun 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with contraception, irritable bowel syndrome (What is irritable bowel syndrome?), rash erythematous and. Topamax dosage: 25 Mg In Am/50 Mg In Pm. During the same period patient was treated with MICRONOR (View Micronor Review and Micronor Label ), CELEXA (View Celexa Review and Celexa Label ), BENTYL (View Bentyl Review and Bentyl Label ), CORTISONE CREAM (View Cortisone Cream Review and Cortisone Cream Label ).

6978967-7 | Cataract, Dysgeusia, Dyspepsia, Dysphagia, Fatigue, Feeling Abnormal, Formication, Hypoaesthesia
Adverse event was reported on Sep 02, 2010 by a Female patient taking Topamax (View Usage) (Dosage: ) was diagnosed with arthralgia, pain in extremity, neuralgia and. Location: UNITED STATES , weighting 157.0 lb, Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), dysgeusia, dyspepsia, dysphagia, fatigue, feeling abnormal, formication, hypoaesthesia.

6978282-1 | Gait Disturbance, Neuralgia
on Sep 03, 2010 Female patient from TURKEY , 22 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). Patient had the following side effects: gait disturbance, neuralgia. Topamax dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ).

6974516-8 | Product Substitution Issue
on Sep 09, 2010 Female patient from UNITED STATES , weighting 133.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: product substitution issue. Topamax dosage: 75 Mg Bid Po.

6972358-0 | Aphasia, Cognitive Disorder
Patient was taking Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cognitive disorder on Sep 01, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , child 7 years of age, weighting 52.91 lb, was diagnosed with epilepsy (What is epilepsy?) and. Topamax dosage: . During the same period patient was treated with CONVULSOFIN (View Convulsofin Review and Convulsofin Label ). Patient was hospitalized.

6972256-2 | Chest Pain, Dyspnoea, Palpitations, Weight Decreased
Adverse event was reported on Aug 31, 2010 by a Female patient taking Topamax (View Usage) (Dosage: ) was diagnosed with migraine prophylaxis, sinus disorder and. Location: UNITED STATES , weighting 185.0 lb, Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, palpitations, weight decreased. During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6968643-9 | Depressed Level Of Consciousness, Hyperpyrexia, Off Label Use
on Sep 02, 2010 Male patient from UNITED KINGDOM , weighting 22.05 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: depressed level of consciousness, hyperpyrexia, off label use. Topamax dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

6968512-4 | Intentional Overdose, Self Injurious Behaviour
on Aug 28, 2010 Female patient from ITALY , 31 years of age, was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, self injurious behaviour. Topamax dosage: .

6968506-9 | Asthenia, Lupus-like Syndrome, Myalgia
Patient was taking Topamax (View Usage). Patient had the following side effects: asthenia, lupus-like syndrome, myalgia on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with contraception, irritable bowel syndrome (What is irritable bowel syndrome?), rash erythematous and. Topamax dosage: 25 Mg In Am/50 Mg In Pm. During the same period patient was treated with MICRONOR (View Micronor Review and Micronor Label ), CELEXA (View Celexa Review and Celexa Label ), BENTYL (View Bentyl Review and Bentyl Label ), CORTISONE CREAM (View Cortisone Cream Review and Cortisone Cream Label ).

6968327-7 | Intentional Overdose, Self Injurious Behaviour
Adverse event was reported on Aug 29, 2010 by a Female patient taking Topamax (View Usage) (Dosage: ) . Location: ITALY , 49 years of age, After Topamax was administered, patient had the following side effects: intentional overdose, self injurious behaviour.

6962071-8 | Convulsion
on Sep 01, 2010 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with convulsion and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Topamax dosage: 1 Tab Bid.

6961054-1 | Oesophageal Ulcer
on Aug 23, 2010 Female patient from UNITED KINGDOM , 14 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). Patient had the following side effects: oesophageal ulcer. Topamax dosage: . During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), MOVICAL (View Movical Review and Movical Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ).

6960553-6 | Ammonia Increased
Patient was taking Topamax (View Usage). After Topamax was administered, patient had the following side effects: ammonia increased on Aug 23, 2010 from GERMANY Additional patient health information: Male patient , weighting 23.37 lb, was diagnosed with infantile spasms and. Topamax dosage: 37.5 Mg - 0 - 25 Mg. During the same period patient was treated with VALPROAT (View Valproat Review and Valproat Label ), SABRIL (View Sabril Review and Sabril Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), MINIRIN (View Minirin Review and Minirin Label ), HYDROCORTISON (View Hydrocortison Review and Hydrocortison Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6960466-X | Asthenia, Cognitive Disorder, Erectile Dysfunction, Feeling Abnormal, Incoherent
Adverse event was reported on Aug 18, 2010 by a Male patient taking Topamax (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?), depression (What is depression?), erectile dysfunction (What is erectile dysfunction?) and. Location: KOREA, REPUBLIC OF , 33 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, cognitive disorder, erectile dysfunction (What is erectile dysfunction?), feeling abnormal, incoherent. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), VIAGRA (View Viagra Review and Viagra Label ).

6955328-8 | Asthenia, Dizziness, Headache, Hypoaesthesia, Nausea, Pain In Extremity, Palpitations
on Aug 26, 2010 Female patient from UNITED STATES , 42 years of age, weighting 152.0 lb, was treated with Topamax (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), headache (What is headache?), hypoaesthesia, nausea (What is nausea?), pain in extremity, palpitations. Topamax dosage: 25mg At Bedtime Po.

6942044-1 | Anger, Convulsion, Fall
on Aug 17, 2010 Female patient from UNITED STATES , weighting 105.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: anger, convulsion, fall (What is fall?). Topamax dosage: . During the same period patient was treated with IMITREX (View Imitrex Review and Imitrex Label ).

6938813-4 | Pregnancy On Oral Contraceptive
Patient was taking Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy on oral contraceptive on Aug 11, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, was diagnosed with convulsion, contraception, affective disorder, bronchitis (What is bronchitis?), anxiety (What is anxiety?) and. Topamax dosage: . During the same period patient was treated with ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ), LAMICTAL (10 Weeks Ga- 20-nov-2010 29 Weeks Ga -25-mar-2010 200mg 37weeks- 20-may-2010) (View Lamictal Review and Lamictal Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), BUSPAR (View Buspar Review and Buspar Label ).

6938811-0 | Cleft Lip And Palate
Adverse event was reported on Aug 11, 2010 by a Male patient taking Topamax (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 7.01 lb, Patient had the following side effects: cleft lip and palate (What is cleft lip and palate?). During the same period patient was treated with ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), BUSPAR (View Buspar Review and Buspar Label ).

6937730-3 | Alopecia
on Aug 20, 2010 Female patient from UNITED STATES , weighting 152.0 lb, was diagnosed with migraine prophylaxis and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: alopecia. Topamax dosage: 100mg 1 X Daily Po.

6937686-3 | Alopecia, Apathy, Balance Disorder, Fall, Fatigue, Flat Affect, Gastrooesophageal Reflux Disease, Hair Texture Abnormal, Hallucination, Visual
on Aug 20, 2010 Female patient from UNITED STATES , 39 years of age, weighting 112.0 lb, was diagnosed with migraine (What is migraine?) and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, apathy, balance disorder, fall (What is fall?), fatigue, flat affect, gastrooesophageal reflux disease, hair texture abnormal, hallucination, visual. Topamax dosage: 100 Mg Every Day Po.

6937666-8 | Myopia, Vision Blurred
Patient was taking Topamax (View Usage). Patient had the following side effects: myopia, vision blurred on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , 37 years of age, weighting 365.0 lb, was diagnosed with migraine (What is migraine?) and. Topamax dosage: 50mg Qd Po.

6935689-6 | Blood Chloride Increased, Carbon Dioxide Abnormal
Adverse event was reported on Aug 13, 2010 by a Female patient taking Topamax (View Usage) (Dosage: ) was diagnosed with impulse-control disorder, bipolar disorder (What is bipolar disorder?), sleep disorder (What is sleep disorder?) and. Location: UNITED STATES , weighting 208.0 lb, After Topamax was administered, patient had the following side effects: blood chloride increased, carbon dioxide abnormal. During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

6935688-4 | Blood Chloride Increased, Carbon Dioxide Decreased
on Aug 13, 2010 Female patient from UNITED STATES , weighting 158.0 lb, was diagnosed with impulse-control disorder, schizophrenia and was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: blood chloride increased, carbon dioxide decreased. Topamax dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CLOZAPINE (100 Mg Tablet In The Am, 250 Mg (100mg+ 100 Mg+ 50 Mg) Tablet In The Pm) (View Clozapine Review and Clozapine Label ).

6935687-2 | Hypersensitivity, Migraine, Rash Pruritic, Treatment Noncompliance
on Aug 13, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with migraine prophylaxis, cystitis and was treated with Topamax (View Usage). Patient had the following side effects: hypersensitivity, migraine (What is migraine?), rash pruritic, treatment noncompliance. Topamax dosage: . During the same period patient was treated with MACRODANTIN (View Macrodantin Review and Macrodantin Label ).

6935686-0 | Apnoea, Blood Bicarbonate Decreased, Blood Phosphorus Decreased, Blood Potassium Decreased, Feeding Disorder, Renal Tubular Acidosis
Patient was taking Topamax (View Usage). After Topamax was administered, patient had the following side effects: apnoea, blood bicarbonate decreased, blood phosphorus decreased, blood potassium decreased, feeding disorder, renal tubular acidosis on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 48.50 lb, was diagnosed with epilepsy (What is epilepsy?) and. Topamax dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), MELATONIN (View Melatonin Review and Melatonin Label ), GAVISCON NOS (View Gaviscon Nos Review and Gaviscon Nos Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ACIDOPHILUS (View Acidophilus Review and Acidophilus Label ), LEVEMIR (View Levemir Review and Levemir Label ), BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

6934033-8 | Aspartate Aminotransferase Increased, Asthenia, Blood Chloride Increased, Blood Sodium Decreased, Electrolyte Imbalance, Gamma-glutamyltransferase Increased, Leukopenia, Restlessness
Adverse event was reported on Aug 12, 2010 by a Male patient taking Topamax (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: GERMANY , 38 years of age, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, asthenia, blood chloride increased, blood sodium decreased, electrolyte imbalance, gamma-glutamyltransferase increased, leukopenia, restlessness. During the same period patient was treated with TIMONIL (View Timonil Review and Timonil Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

6934024-7 | De Lange's Syndrome, Impaired Gastric Emptying, Oesophageal Ulcer
on Aug 12, 2010 Female patient from UNITED KINGDOM , 15 years of age, was treated with Topamax (View Usage). Patient had the following side effects: de lange's syndrome, impaired gastric emptying, oesophageal ulcer. Topamax dosage: .

6933601-7 | Attention Deficit/hyperactivity Disorder, Migraine, Vomiting
on Aug 11, 2010 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with migraine prophylaxis and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: attention deficit/hyperactivity disorder, migraine (What is migraine?), vomiting. Topamax dosage: 50 Mg, 1 In Morning And 2 In Evening.. During the same period patient was treated with TOPIRAMATE (50 Mg, 1 In Morning And 2 In Evening.) (View Topiramate Review and Topiramate Label ).

6932611-3 | Anaphylactic Reaction
Patient was taking Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction on Aug 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 23 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Topamax dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

6929899-1 | Neuropathy Peripheral
Adverse event was reported on Aug 17, 2010 by a Female patient taking Topamax (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 142.0 lb, Patient had the following side effects: neuropathy peripheral.

6929556-1 | Coronary Artery Occlusion, Fatigue, Migraine, Nausea, Tuberculin Test Positive
on Aug 09, 2010 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), migraine (What is migraine?), tuberculin test positive, blood cholesterol increased, hypertension and was treated with Topamax (View Usage). After Topamax was administered, patient had the following side effects: coronary artery occlusion, fatigue, migraine (What is migraine?), nausea (What is nausea?), tuberculin test positive. Topamax dosage: . During the same period patient was treated with ADALIMUMAB (40 Mg/0.8 Ml In Two Doses.) (View Adalimumab Review and Adalimumab Label ), PREDNICARBATE (25 Mg, 6 In 1 Day) (View Prednicarbate Review and Prednicarbate Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PLAVIX (View Plavix Review and Plavix Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BISELECT (2.5 Mg Once A Day) (View Biselect Review and Biselect Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6924984-2 | Self Injurious Behaviour
on Aug 07, 2010 Male patient from ITALY , 41 years of age, was treated with Topamax (View Usage). Patient experienced the following unwanted or unexpected effects: self injurious behaviour. Topamax dosage: . During the same period patient was treated with SEREUPIN (View Sereupin Review and Sereupin Label ).

6923759-8 | Nasopharyngitis, Osteomyelitis
Patient was taking Topamax (View Usage). Patient had the following side effects: nasopharyngitis, osteomyelitis on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with pain (What is pain?), inflammation, gastric ulcer and. Topamax dosage: . During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), PREVACID (View Prevacid Review and Prevacid Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NORCO (10/325mg As Needed) (View Norco Review and Norco Label ), DURAGESIC 100 (75 Mcg +50 Mcg) (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.